Primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue-type in the thymus of a patient with Sjögren's syndrome and rheumatoid arthritis. by Kim, Jin-Man
INTRODUCTION
Extranodal lymphoma of mucosa-associated lymphoid tis-
sue (MALT) was first described by Isaacson and Wright in
1983 (1) and was recently reclassified as  “extranodal marginal
zone B-cell lymphoma (MZBL) of MALT-type” according to
the REAL (2) and WHO classifications (3). Primary MZBLs
of MALT-type have been described in a variety of sites, includ-
ing gastrointestinal tract (1), thyroid gland (4) , lung (5), sali-
vary gland (6), and ocular adnexa (7) associated with clinical
setting of autoimmune diseases or chronic inflammation, usu-
ally Sjogren’ s syndrome, Hashimoto’ s thyroiditis, and Heli-
cobacter pylori infection. Thymic MZBL of MALT-type is an
extremely rare disease with only 22 cases having been report-
ed in the literature to date and the largest series has included
15 cases (8-19). In this paper, I report a case of low-grade
MZBL of MALT-type in the thymus of a patient with Sjo-
gren’ s syndrome and rheumatoid arthritis.
CASE REPORT
A 43-yr-old Korean woman presented with a long history
of Sjogren’ s syndrome and rheumatoid arthritis. She had com-
plained of dry eyes, dry mouth, and arthralgia for about 16 yr
and also complained of both parotid swelling that had devel-
oped 3 months before. The symmetrical swelling of the wrist,
metacarpophalangeal, and proximal interphalangeal joints was
accompanied by morning stiffness and pain. On admission,
antinuclear antibody (ANA) revealed a speckled pattern and
showed positive reaction for SS-A/Ro antibody and negative
for the SS-B/La antibody. Rheumatoid factor was positive
(147.3 IU/mL). A lobulated anterior mediastinal mass was
detected by computerized tomography (Fig. 1) and the thy-
mus was resected through median sternotomy. There were no
symptoms of myasthenia gravis. The resected mass was con-
fined within the thymus and did not show invasion to the
surrounding structures. The specimen consisted of a solid,
smooth, lobulated, encapsulated mass that measured 7 cm in
maximum diameter and weighed 79 g. The cut surface was
pale pink to tan, and showed homogenous appearance with
some small cysts (Fig. 2). The tissue was fixed in 10% neutral
buffered formalin and embedded in paraffin. Sections were
stained with hematoxylin and eosin and periodic acid-Schiff.
Histologically, the normal architecture of the thymus was dif-
fusely effaced by a dense infiltration of lymphoid cells. Reac-
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Primary Extranodal Marginal Zone B-cell Lymphoma of 
Mucosa-Associated Lymphoid Tissue-type in the Thymus of
a Patient with Sjogren's Syndrome and Rheumatoid Arthritis
Primary thymic marginal zone B-cell lymphoma (MZBL) of mucosa-associated
lymphoid tissue (MALT)-type is a very rare disease with distinct clinicopathologic
features. I herein report a rare case of primary thymic MZBL of MALT-type arising
in the thymus in a patient with Sjogren’ s syndrome and rheumatoid arthritis. A
mediastinal mass was detected by computerized tomography in a 43-yr-old Korean
woman with a history of Sjogren’ s syndrome and rheumatoid arthritis and the thy-
mus was resected through median sternotomy. The solid and nodular tumor (7×6
×3 cm) was confined in the thymus. Histologically, the lymphoid infiltrate com-
prised monotonous centrocyte-like cells with monocytoid cells, small lymphocytes,
and plasma cells. Prominent lymphoepithelial lesions were formed by centrocyte-like
cells infiltrating the Hassall’ s corpuscles. Immunohistochemically, the tumor cells
were positive for CD20, CD79a, and bcl-2 and negative for CD3, CD5, CD10, CD23,
and bcl-6. IgA and kappa light chain restriction were also found in plasma cells in
the tumor. Sjogren’ s syndrome and rheumatoid arthritis are known to be associated
with MALT lymphoma and were considered to play an important role in the devel-
opment of malignant lymphoma in this patient.
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tive lymphoid follicles with germinal centers could be iden-
tified within the tumor (Fig. 3A). The microscopic cysts filled
with eosinophilic proteinaceous fluid were lined by attenuat-
ed epithelium infiltrated by centrocyte-like (CCL) cells (Fig.
3B). The lymphoid infiltrate comprised monotonous CCL cells
with monocytoid cells and plasma cells (Fig. 3C, D). There
were considerable number of plasma cells and small lympho-
cytes. A few large transformed cells were also recognized (Fig.
Fig. 1. CT scan shows a relatively well-demarcated lobulated solid
mass in the anterior mediastinum.
Fig. 2. The cut surface of the thymic tumor shows pale pink to tan,
solid, homogeneous and lobulated tissue with some small cysts.
Fig. 3. The low-power view shows totally effaced architecture with
diffuse lymphoid infiltration and interspersed reactive lymphoid fol-
licles (A, H&E, ×200). Focal variable-sized cysts containing eosi-
nophilic fluid (B, H&E, ×100). Neoplastic cells are predominantly
composed of centrocyte-like (CCL) cells, small lymphocytes, and
plasma cells (C, H&E, ×400). Sheets of CCL cells with monocy-
toid feature (D, H&E, ×400).
A B
C D
Fig. 4. Infiltration and expansion of Hassall’ s corpuscles by neoplas-
tic cells forming a lymphoepithelial lesion is noted (A, H&E, ×400)
and highlightened by an immunostaining for cytokeratin (B, ×400).
Thymic lymphoma showing positive reaction  for CD20 (C, ×400).
Some plasma cells show cytoplasmic staining for kappa light chain
(D, ×400), whereas lambda light chain is negative (E, ×400).
A B
C D E3C). Prominent lymphoepithelial lesions (LEL), which were
highlightened by cytokeratin staining, were formed by cen-
trocyte-like cells infiltrating and expanding the Hassall’ s cor-
puscles (Fig. 4A, B). Immunohistochemical studies of paraffin
sections were performed with the use of LSAB kit (DAKO,
Carpinteria, CA, U.S.A.). The primary antibodies for the kappa
light chain, lambda light chain, and CD3 were purchased from
DiNona, Korea and primary antibodies for the CD20, CD79a,
bcl-2, bcl-6, CD5, CD23, CD10, and cytokeratin were pur-
chased from DAKO. Immunohistochemically, the CCL cells
were positive for CD20, CD79a, and bcl-2 indicating B-cell
phenotype (Fig. 4C) and negative for CD3, CD5, CD10, CD23,
and bcl-6. Kappa light chain restriction was also found in pl-
asma cells in the tumor confirming monoclonality of B-cell
proliferation (Fig. 4D, E). The tumor cells showed IgA heavy-
chain type. A variable number of CD3-positive T cells were
admixed with CCL cells. Postoperative adjuvant chemother-
apy or radiation therapy was not given. The patient has been
followed up for 11 months without evidence of recurrent tumor.
DISCUSSION
I herein report a case of primary extranodal MZBL of
MALT-type in the thymus associated with Sjogren’ s syndrome
and rheumatoid arthritis. MZBL of MALT-type is character-
ized by an indolent clinical course and has been described in
a variety of sites (1, 4-7) associated with clinical setting of au-
toimmune diseases and chronic inflammation, usually Sjogren’ s
syndrome, Hashimoto’ s thyroiditis, and Helicobacter pylori infec-
tions which suggests proliferation of the lymphoma cells de-
pend on the presence of antigen-driven T cells.
Thymic MZBL of MALT-type is an extremely rare disease
with only 22 cases having been reported in the literature to
date, including one Korean case (8-19). According to Inagaki
et al. (19) who systematically investigated 15 cases of thymic
MALT lymphoma, this tumor entity revealed prevalence in
Asians, marked female predilection, strong association with
autoimmune diseases, especially Sjogren’ s syndrome, mostly
IgA phenotype, and consistent lack of API2-MLT1 gene fu-
sion, a recently reported MALT lymphoma-specific gene abnor-
mality. They proposed that thymic MALT lymphoma is a dis-
tinct subgroup of MALT lymphoma. The association with
rheumatoid arthritis was reported in only one case (11). No
cases associated with both Sjogren’ s syndrome and rheuma-
toid arthritis as in my case were reported.
B-cell lymphomas other than MALT lymphoma arise in the
thymus, especially mediastinal large B-cell lymphoma, which
has been included in the REAL (2) and WHO classifications
(3). In contrast to MALT lymphoma which shows an indolent
course, this tumor is a highly aggressive lymphoma with a
poor prognosis. The mixture of epithelial elements and small
lymphocytes could be confused with more common thymoma.
In type B thymomas, the lymphoid cells usually consist of
small immature lymphocytes of T-cell immunophenotype,
whereas in the thymic MALT lymphoma there is an admix-
ture of small lymphocytes, CCL cells, a few blastoid cells, and
plasma cells showing mostly B-cell immunophenotype.
In summary, I described herein is a thymic low-grade ex-
tranodal MZBL of MALT-type in a patient with both Sjogren’ s
syndrome and rheumatoid arthritis. It is possible that the ly-
mphoma arose on the underlying basis of long standing auto-
immune diseases. Pathologists should be aware that MZBL
of MALT-type may occasionally involve thymus. In a small
biopsy, the presence of mixture of small lymphoid cells and
epithelial cells may closely mimic a thymoma. Morphologic
features of CCL cells, plasmacytoid cells, lymphoepithelial
lesions as well as immunophenotype or molecular studies are
helpful for a definitive diagnosis.
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